Phage therapy combats pandrug-resistant Acinetobacter baumannii infection safely and efficiently

  30 May 2024

This study investigates the effectiveness of phage therapy against A. baumannii strains with KL160 CPS, including pan-drug resistant A. baumannii YQ4. The lytic phage, ФAb4B, effectively inhibited biofilm formation and eradicated mature biofilms without cytotoxic or hemolytic effects. Phage therapy improved neutrophil counts, outperforming ciprofloxacin. Combinatorial treatment of phage-CIP saved 91% of mice, independent of dosage. Bacterial resistance was not a contributing factor to treatment failure.

Author(s): Wei-Xiao Wang et al
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed